Print this page    •   Back to Web version of article

Expanded Access to Tenofovir

By Sean R. Hosein

October 9, 2001

Tenofovir, also known as Viread, is a type of anti-HIV drug called a nucleotide reverse transcriptase inhibitor. Tenofovir is not a major breakthough -- it is not as potent as, say, the protease inhibitor indinavir (Crixivan). However, the advantage with tenofovir is that it only has to be taken once a day. Tenofovir will likely be approved for use only in people who have previously used anti-HIV medications. Until then, the manufacturer, Gilead Sciences, is making tenofovir available at no cost for physicians to give to some people with HIV/AIDS in the following countries: Gilead will consider requests for tenofovir from physicians in Canada for their patients with the following profile: For more information about the tenofovir expanded access program or to register patients in Canada and the U.S., physicians can phone: 1.877.226.8802. Physicians in Europe can call this number: 33.1.44.90.34.46.

Registration materials can be requested online by visiting the Gilead website at: http://www.gilead.com/webpage_templates/frame_home.php3.

A CATIE fact sheet about tenofovir is under development and will be available shortly.




This article was provided by Canadian AIDS Treatment Information Exchange. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art30240.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.